Drugs Made In America Acquisition (DMII) Cash from Operations (2025)
Drugs Made In America Acquisition (DMII) reported Cash from Operations of 314864.0 for Q4 2025.
Drugs Made In America Acquisition (DMII) Cash from Operations (2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has 1 years of Cash from Operations data on file, last reported at 314864.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | -121,028.00 |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | 10,832.00 |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | -119,667.00 |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | -334,671.00 |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | -72,157.00 |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | -195,797.00 |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | 1.32 Mn |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | -171,240.00 |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | -204,942.00 |
| 10 | Drugs Made In America Acquisition | 129.34 Mn | 129.34 Mn | - | -314,864.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -314,864.00 |
| Dec 31, 2025 | -314,864.00 |